Trial for free
    ‹ All Posts

    Topic: ESG

    Deal Screening - ManTech
    ESG |

    Deal Screening: ManTech

    This is from SESAMm’s Deal Screening AI report. These reports are usually used by private equity deal teams and M&A...

    Read More
    By: SESAMm | 2 minute read
    |

    The ESG Scorecard: A Deep Dive into High-Growth Chinese Companies

    Chinese companies face elevated ESG risk exposure as scale, rapid growth, and cross-border operations intersect with...

    Mar 11, 2026
    |

    How Private Markets Outgrew Static ESG Due Diligence

    For decades, private market investors have relied on upfront due diligence as the primary moment to assess ESG,...

    Mar 3, 2026
    |

    The Risk of Quiet Portfolios: ESG Blind Spots in Private Markets

    In theory, a portfolio with no ESG controversies signals low risk. In practice, experienced analysts treat it as a...

    Feb 19, 2026
    |

    ESG Assessment: Eureden

    Eureden is a large farmer‑owned French agri‑food co‑operative headquartered in Brittany, combining upstream...

    Feb 18, 2026
    |

    The ESG Scorecard: A Deep Dive into the Pharmaceutical Industry

    There’s no denying that ESG risk exposure in the pharmaceutical industry is high. This stems from the intense...

    Feb 4, 2026
    | |

    A Clearer View of Risk: A New Year's Message from SESAMm

    As 2026 kicks off, I want to take a moment to reflect on the year we’ve just closed. 2025 was an important year for...

    Jan 21, 2026
    |

    The ESG Scorecard: A Deep Dive into The Biotech Industry

    The biotech industry faces significant ESG risks, particularly in governance. Social and operational risks are less...

    Jan 8, 2026
    |

    November’s Fundamental Human Rights Controversies: A Market Analysis

    Human rights concerns took center stage in November, with rising scrutiny on how digital platforms and luxury brands...

    Dec 16, 2025
    |

    When Markets Move at Machine Speed: Why Corporate Crisis Response Must Evolve

    When Meta's market value declined by $307 billion over four trading days in October 2025, it demonstrated a fundamental...

    Dec 15, 2025